This article has been retracted: Curcumin targets Akt cell survival signaling pathway in HTLV‐I‐infected T‐cell lines

This article has been retracted at the request of Editor‐in‐Chief & Author.

[1]  Yuetsu Tanaka,et al.  Curcumin suppresses constitutive activation of AP-1 by downregulation of JunD protein in HTLV-1-infected T-cell lines. , 2006, Leukemia research.

[2]  Yuetsu Tanaka,et al.  Retracted: Curcumin (diferuloylmethane) inhibits constitutive active NF‐κB, leading to suppression of cell growth of human T‐cell leukemia virus type I‐infected T‐cell lines and primary adult T‐cell leukemia cells , 2006 .

[3]  J. Brady,et al.  Activated AKT regulates NF-κB activation, p53 inhibition and cell survival in HTLV-1-transformed cells , 2005, Oncogene.

[4]  J. Choe,et al.  The Kaposi's sarcoma-associated herpesvirus K-bZIP protein represses transforming growth factor β signaling through interaction with CREB-binding protein , 2004, Oncogene.

[5]  L. Cantley,et al.  Targeting the PI3K-Akt pathway in human cancer: rationale and promise. , 2003, Cancer cell.

[6]  B. Aggarwal,et al.  Curcumin (Diferuloylmethane) Inhibits Constitutive and IL-6-Inducible STAT3 Phosphorylation in Human Multiple Myeloma Cells 1 , 2003, The Journal of Immunology.

[7]  Young-ho Kim,et al.  Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. , 2003, Carcinogenesis.

[8]  T. Slaga,et al.  4-Hydroxy-3-methoxybenzoic acid methyl ester: a curcumin derivative targets Akt/NF kappa B cell survival signaling pathway: potential for prostate cancer management. , 2003, Neoplasia.

[9]  L. Chaudhary,et al.  Inhibition of cell survival signal protein kinase B/Akt by curcumin in human prostate cancer cells , 2003, Journal of cellular biochemistry.

[10]  J. Litz,et al.  Inhibition of phosphatidylinositol 3-kinase-Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapy. , 2002, Molecular cancer therapeutics.

[11]  Lewis C Cantley,et al.  The phosphoinositide 3-kinase pathway. , 2002, Science.

[12]  Y. Surh,et al.  Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. , 2002, Journal of biochemistry and molecular biology.

[13]  B. Hemmings,et al.  Inhibition of protein kinase B/Akt. implications for cancer therapy. , 2002, Pharmacology & therapeutics.

[14]  P. Dennis,et al.  Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. , 2001, Cancer research.

[15]  M. Yamakuchi,et al.  Phosphoinositide-3 kinase-PKB/Akt pathway activation is involved in fibroblast Rat-1 transformation by human T-cell leukemia virus type I tax , 2001, Oncogene.

[16]  M. Tomonaga,et al.  A new G‐CSF‐supported combination chemotherapy, LSG15, for adult T‐cell leukaemia‐lymphoma: Japan Clinical Oncology Group Study 9303 , 2001, British journal of haematology.

[17]  Y Taya,et al.  Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. , 2000, Genes & development.

[18]  M. Tomonaga,et al.  Constitutive activation of transcription factor AP-1 in primary adult T-cell leukemia cells. , 2000, Blood.

[19]  A. Newton,et al.  Akt/Protein Kinase B Is Regulated by Autophosphorylation at the Hypothetical PDK-2 Site* , 2000, The Journal of Biological Chemistry.

[20]  L. Howells,et al.  Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex , 1999, Oncogene.

[21]  A. Casamayor,et al.  PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2 , 1999, Current Biology.

[22]  M. Tomonaga,et al.  Constitutive Activation Of Nf- κ B In Primary Adult T-cell Leukemia Cells , 1999 .

[23]  M. Roussel,et al.  Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. , 1998, Genes & development.

[24]  T. Tan,et al.  Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin , 1998, Oncogene.

[25]  B. Burgering,et al.  Essential Role for Protein Kinase B (PKB) in Insulin-induced Glycogen Synthase Kinase 3 Inactivation , 1998, The Journal of Biological Chemistry.

[26]  F. McCormick,et al.  Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. , 1998, Science.

[27]  P. Cohen,et al.  Role of Translocation in the Activation and Function of Protein Kinase B* , 1997, The Journal of Biological Chemistry.

[28]  P. Cohen,et al.  Mechanism of activation of protein kinase B by insulin and IGF‐1. , 1996, The EMBO journal.

[29]  M. Ishiyama,et al.  A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. , 1996, Biological & pharmaceutical bulletin.

[30]  B. Aggarwal,et al.  Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane) (*) , 1995, The Journal of Biological Chemistry.

[31]  W. Leonard,et al.  Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. , 1995, Science.

[32]  B. Aggarwal,et al.  The p60 Tumor Necrosis Factor (TNF) Receptor-associated Kinase (TRAK) Binds Residues 344–397 within the Cytoplasmic Domain Involved in TNF Signaling (*) , 1995, The Journal of Biological Chemistry.

[33]  K Y Hui,et al.  A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). , 1994, The Journal of biological chemistry.

[34]  Jen-kun Lin,et al.  Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells. , 1993, Carcinogenesis.

[35]  Y. P. Lu,et al.  Inhibitory effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced increase in ornithine decarboxylase mRNA in mouse epidermis. , 1993, Carcinogenesis.

[36]  Jen-kun Lin,et al.  Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[37]  H. Ammon,et al.  Pharmacology of Curcuma longa , 1991, Planta medica.

[38]  A. Bhigjee,et al.  Blood transfusion and HTLV-I-associated myelopathy. , 1989, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[39]  F. Barin,et al.  ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS , 1985, The Lancet.

[40]  H. Koeffler,et al.  Characterization of a novel HTLV-infected cell line. , 1984, Blood.

[41]  D. Mann,et al.  Isolation and transmission of human retrovirus (human t-cell leukemia virus). , 1983, Science.

[42]  M. Yoshida,et al.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Y. Ohtsuki,et al.  Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells , 1981, Nature.

[44]  John D. Minna,et al.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma , 1980, Proceedings of the National Academy of Sciences.

[45]  Yuetsu Tanaka,et al.  Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells. , 2006, International journal of cancer.

[46]  M. Pirmohamed,et al.  Phase I Clinical Trial of Oral Curcumin: Biomarkers of Systemic Activity and Compliance , 2004 .

[47]  K. Frenkel,et al.  Inhibitory effects of curcumin on tumorigenesis in mice , 1997, Journal of cellular biochemistry. Supplement.

[48]  J. Xie,et al.  Inhibitory effects of topical application of low doses of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and oxidized DNA bases in mouse epidermis. , 1997, Carcinogenesis.

[49]  H. Towler,et al.  Adult T-cell leukemia : antigen in an ATL cell line and detection of antibodies to the antigen in human sera , 2022 .